|
Market Closed -
Australian S.E.
03:59:31 09/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.0820 AUD | -7.87% |
|
-2.38% | -45.33% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 42.09 | - | - |
| Change | - | - | 343.99% | -65.09% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 24.19 | 18.69 | 24.69 |
| Change | - | - | 241.42% | -73.91% | -22.74% | 32.1% |
| P/E | -2.64x | -3.27x | -14.3x | -3.57x | -11.7x | -7.45x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.2x | -0.1x |
| Capitalization / Revenue | - | - | - | - | 4.43x | 4.43x |
| EV / Revenue | - | - | - | - | 1.97x | 2.6x |
| EV / EBITDA | - | - | -11.2x | -2.1x | -4.67x | -4.12x |
| EV / EBIT | - | - | -11.1x | -2.09x | -4.56x | -4.05x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.0820 | 0.0820 | 0.0820 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/5/23 | 30/5/25 | 29/5/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87x | - | -2.42x | - | 31.42M | |
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | |
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | |
| 46.55x | 6.14x | 30.16x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.71x | 62.58x | -21.48x | -.--% | 41.59B | |
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 41.46x | 8.08x | 26.8x | -.--% | 33.29B | |
| -69.81x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 14.89x | 13.78x | 5.96x | 0.33% | 40.68B | |
| Weighted average by Cap. | 21.51x | 12.92x | 11.34x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
